Royalty Pharma plc - Class A — 貸借対照表 (NASDAQ:RPRX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計配当金

総資産 16.02 B17.52 B16.81 B16.38 B18.22 B19.62 B 負債合計 6.12 B7.27 B7.29 B6.3 B7.88 B9.91 B 純資産合計 9.9 B10.25 B9.53 B10.08 B10.34 B9.71 B 負債および純資産合計 16.02 B17.52 B16.81 B16.38 B18.22 B19.62 B 有利子負債合計 5.82 B7.1 B7.12 B6.14 B7.61 B8.95 B 純負債 3.75 B4.91 B4.38 B5.64 B5.63 B7.95 B

ニュース

Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?

Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?

Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?

Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?

Defense Lifts Moat Stocks As Tech Stumbles

ロイヤルティ・ファーマ、TD Cowenカンファレンスで戦略的成長の見通しを示す

Royalty Pharma at TD Cowen Conference: Strategic Growth Insights

Stifelがロイヤリティ契約の価値を評価しZymeworks株の目標株価を引き上げ

Citizens reiterates Zymeworks stock rating on strong cash position

Zymeworks、2025年スライドでZiiheraの勢いにより売上高176%増を示す